Learn More
Medchemexpress LLC Ergi-USU-6 mesylate | 2756327-67-8 | 95.0% | C14H18N4O4S | 10MG

Supplier: Medchemexpress LLC HY13989310MG
ERGi-USU-6 mesylate is a research-grade small-molecule inhibitor of ERG and RIOK2 with reported cellular potency (IC50 ≈ 0.13-0.17 μM in VCaP cells). The methanesulfonate salt is supplied as a solid with a reported purity of 95% and is intended for in vitro and preclinical research use.
- Inhibits ERG and RIOK2 with submicromolar cellular potency.
- Demonstrates antiproliferative activity in ERG-positive prostate cancer models.
- Supplied as a mesylate salt for improved handling and stability.
- High reported purity suitable for biochemical and cell-based assays.
- Solid form with defined cold-storage recommendations for sample integrity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.